Autonomix Medical (AMIX) News Today $3.00 +0.07 (+2.22%) As of 01:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual MeetingFebruary 20 at 8:30 AM | globenewswire.comAutonomix Medical, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceFebruary 19 at 12:39 PM | finance.yahoo.comAutonomix Medical Announces Third Quarter Fiscal Year 2025 Financial Results and Operational HighlightsFebruary 16, 2025 | americanbankingnews.comAutonomix Medical, Inc. Reports Progress in Pancreatic Cancer Pain Clinical Trial and Financial Results for Q3 FY 2025February 13, 2025 | quiverquant.comAutonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate UpdateFebruary 13, 2025 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner SegmentJanuary 24, 2025 | globenewswire.comAutonomix Medical CEO Engages in Investor SeriesJanuary 22, 2025 | tipranks.comAutonomix finalizes design of ASIC microchip for sensing technology catheterJanuary 17, 2025 | markets.businessinsider.comAutonomix Medical finalizes ASIC microchip designJanuary 17, 2025 | msn.comAutonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025January 17, 2025 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell SeriesJanuary 15, 2025 | globenewswire.comAutonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific MeetingJanuary 13, 2025 | globenewswire.comAutonomix granted U.S. patent for catheter-based technologyDecember 31, 2024 | markets.businessinsider.comAutonomix Medical Shares Rise on New Patent for Cancer TreatmentDecember 30, 2024 | marketwatch.comAutonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based TechnologyDecember 30, 2024 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner SegmentDecember 23, 2024 | globenewswire.comAutonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and QualityDecember 19, 2024 | finance.yahoo.comAutonomix achieves design lock for RF Ablation CatheterDecember 6, 2024 | markets.businessinsider.comAutonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025December 5, 2024 | globenewswire.comAutonomix Medical stock dips after pricing $9M securities offeringNovember 25, 2024 | msn.comAutonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment OptionNovember 25, 2024 | globenewswire.comAutonomix Medical Down 53% After Pricing of $9M OfferingNovember 23, 2024 | marketwatch.comAutonomix to sell 1.38M units at $6.54 in underwritten public offeringNovember 23, 2024 | markets.businessinsider.comAutonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public OfferingNovember 22, 2024 | globenewswire.comAutonomix reports Q2 incurred net losses $2.8M vs $6M last yearNovember 12, 2024 | markets.businessinsider.comAutonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate UpdateNovember 11, 2024 | globenewswire.comAutonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain TreatmentNovember 1, 2024 | marketwatch.comAutonomix reports results from first 15 patients’ data on transvascular energyNovember 1, 2024 | msn.comAutonomix participates in Virtual Investor ‘What This Means’ segmentOctober 31, 2024 | markets.businessinsider.comAutonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical TrialOctober 30, 2024 | globenewswire.comAutonomix Medical Inc trading resumesOctober 28, 2024 | markets.businessinsider.comAutonomix Medical Inc trading halted, volatility trading pauseOctober 28, 2024 | markets.businessinsider.comAutonomix Shares Soar 85% on Results From Pain-Management StudyOctober 28, 2024 | marketwatch.comWhy Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?October 28, 2024 | benzinga.comCrude Oil Tumbles Over 5%; Autonomix Medical Shares Spike HigherOctober 28, 2024 | benzinga.comAutonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Drop in Short InterestAutonomix Medical, Inc. (NASDAQ:AMIX - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 136,100 shares, a decline of 23.7% from the September 30th total of 178,400 shares. Based on an average trading volume of 420,800 shares, the days-to-cover ratio is currently 0.3 days. Currently, 1.1% of the company's shares are sold short.October 27, 2024 | marketbeat.comAutonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30thOctober 25, 2024 | globenewswire.comAutonomix Medical Inc trading halted, news pendingOctober 25, 2024 | markets.businessinsider.comAutonomix Announces 1-for-20 Reverse Stock SplitOctober 22, 2024 | markets.businessinsider.comAutonomix Announces Reverse Stock SplitOctober 22, 2024 | globenewswire.comAutonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLCOctober 8, 2024 | globenewswire.comAutonomix Medical (NASDAQ:AMIX) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comThis Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic CancerOctober 4, 2024 | finance.yahoo.comAutonomix Flat on Unveiling Corner SegmentSeptember 26, 2024 | baystreet.caAutonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner SegmentSeptember 26, 2024 | globenewswire.comAutonomix Selected to Present at the 2024 Octane Medical Innovation ForumSeptember 20, 2024 | globenewswire.comAutonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 27, 2024 | globenewswire.comAutonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual CongressAugust 21, 2024 | globenewswire.comAMIX Stock Earnings: Autonomix Medical Reported Results for Q1 2025August 14, 2024 | markets.businessinsider.comAutonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term MilestonesAugust 13, 2024 | globenewswire.com Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address AMIX Media Mentions By Week AMIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMIX News Sentiment▼0.000.60▲Average Medical News Sentiment AMIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMIX Articles This Week▼31▲AMIX Articles Average Week Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bellevue Life Sciences Acquisition News Today Innovative Eyewear News Today STRATA Skin Sciences News Today Inspira Technologies Oxy B.H.N. News Today Intelligent Bio Solutions News Today Predictive Oncology News Today Biotricity News Today Cutera News Today QT Imaging News Today NeuroMetrix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMIX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.